Egis World

Egis is present in 61 countries with its products.

Click here to learn more

Pharma Company

Our activities incorporate all areas in the pharmaceutical value chain

Click here to learn more

Research & Development

One of the fundamental pillars of our strategy is innovation. We devoted about EUR 45 million to research and development in the 2020/2021 financial year.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners

Egis World

Egis is present in 61 countries with its products.

Our portfolio contains 634 products. Our highlighted therapeutical areas are the cardiovascular system, the central nervous system and the respiratory system.

Learn more

A place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for our medical and pharmaceutical visitors. These contents are available with password protection - please contact our representative or require your own account at the Contact menu.

Learn more
Main therapic areas
Main therapic areas
Cardiovascular system
Central nervous system
Gastroenterology
Women´s health

Pharmacovigilance, Adverse event reporting

Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, to any of the listed contacts below.

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox